Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Planuj i Chroń: Planowanie Bezpieczeństwa dla Młodzieży w Wiejskich Oddziałach Ratunkowych

29 września 2026 zaktualizowane przez: JoAnna K. Leyenaar, Dartmouth-Hitchcock Medical Center

Opracowanie i wdrożenie kulturowo wrażliwego planowania bezpieczeństwa w celu zmniejszenia ryzyka samobójstw wśród nastolatków poszukujących opieki na wiejskich oddziałach ratunkowych

The goal of this observational study is to determine whether implementing a culturally sensitive, tablet-based safety planning program called Plan & Protect (P&P) within rural emergency departments can improve home safety and reduce suicide risk in adolescents presenting to the emergency department with suicide-related concerns.

The main questions it aims to answer are:

  • Will implementing P&P increase caregiver-reported home safety (reduce access to firearms and unsafe medication storage) for adolescents 12-17 years old presenting to rural EDs with suicidal ideation, self-harm, or mental health crisis?
  • Will implementing P&P decrease adolescent-reported perceived suicide risk and related outcomes (e.g., suicide events, and attendance at follow-up mental healthcare)?

Researchers will compare outcomes for adolescents and caregivers receiving P&P (implemented as the new standard of care at sites during the intervention periods) to those receiving usual care (prior to P&P implementation at those hospitals) to see if P&P increases home safety and decreases suicide risk and related healthcare utilization.

Participants will, if clinically appropriate:

  • Complete the tablet-based P&P modules during their ED visit
  • Complete self-report measures at baseline, ~30 days, and ~3 months post-discharge
  • A subset will also participate in semi-structured interviews

Przegląd badań

Szczegółowy opis

One-in-five children and adolescents in the United States (US) live in rural areas where they are more likely to live in poverty, have neurodevelopmental, behavioral and mental health conditions, and die during childhood than their urban-residing peers. Suicide is a leading cause of childhood mortality, and rural-residing youth are two times more likely to die from suicide than urban-residing youth. Nearly half of children and adolescents with mental health conditions do not receive treatment, and those in rural areas face unique barriers to care due to geographic isolation, stigma, and shortages of pediatric services and clinicians. Given barriers to community-based mental healthcare, youth with suicidal ideation and/or suicide attempt (hereafter "suicidality") increasingly present to emergency departments (EDs) for care. However, most clinicians practicing in rural EDs are under-prepared and under-resourced to care for this population.

In order to fill this gap, this project aims to improve home safety and decrease suicide risk in youth 12-17 years of age who present to rural EDs with suicidal ideation, attempt, or mental health crisis, leveraging community-based participatory research approaches and technology to implement, with high fidelity, culturally-sensitive and nationally recommended safety planning procedures. To achieve this goal, we will integrate P&P, a culturally sensitive, tablet-based safety planning program as a quality improvement intervention at 5 hospitals in the Dartmouth Health network using a hospital-randomized stepped wedge design and will evaluate the program using a type 1 hybrid implementation-effectiveness design.

Aim: To determine the effectiveness of P&P compared to usual care for youth with suicide-related concerns and their caregivers to increase home safety and decrease suicide risk; evaluate the extent to which these outcomes are mediated by caregiver and youth self-efficacy and expectations of suicide risk; and assess the reach, effectiveness, adoption, implementation and maintenance of P&P using a mixed methods approach.

Typ studiów

Interwencyjne

Zapisy (Szacowany)

550

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Lokalizacje studiów

    • New Hampshire
      • Claremont, New Hampshire, Stany Zjednoczone, 03756
      • Keene, New Hampshire, Stany Zjednoczone, 03431
        • Rekrutacyjny
        • Cheshire Medical Center
        • Kontakt:
        • Główny śledczy:
          • Maia Rutman, MD
      • Lebanon, New Hampshire, Stany Zjednoczone, 03756
        • Rekrutacyjny
        • Dartmouth-Hitchcock Medical Center
        • Kontakt:
        • Główny śledczy:
          • Maia Rutman, MD
      • Lebanon, New Hampshire, Stany Zjednoczone, 03766
        • Rekrutacyjny
        • Alice Peck Day Memorial Hospital
        • Główny śledczy:
          • Maia Rutman, MD
        • Kontakt:
      • New London, New Hampshire, Stany Zjednoczone, 03257
        • Rekrutacyjny
        • New London Hospital
        • Kontakt:
        • Główny śledczy:
          • Maia Rutman, MD
    • Vermont
      • Windsor, Vermont, Stany Zjednoczone, 05089

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

12 lat i starsze (Dziecko, Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion criteria for children:

  • 12-17 years of age (and their parent/caregiver(s))
  • Ability to speak and complete surveys in English
  • History of emergency department visit for suicidality, self-harm or mental health crisis
  • Medically stable

Exclusion criteria for children:

  • Cognitive or developmental delays that preclude program participation based on clinical team assessment
  • Diagnosis of psychosis
  • Primary diagnosis of an eating disorder
  • Parent/guardian not able to provide consent in English
  • Clinical team concern for patient or staff safety based upon active behavioral concerns
  • Parent/guardian not available to provide consent (e.g youth is in child protective custody/ward of the state)

Inclusion criteria for parents/caregivers:

  • Parent or caregiver of an eligible child
  • 18 years old or older
  • Ability to speak and complete surveys in English

Exclusion criteria for parents/caregivers:

-Inability to understand key aspects of the study

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Badania usług zdrowotnych
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Plan & Protect

Plan and Protect is a tablet-based program that integrates a youth-facing safety-planning module with a caregiver-facing home safety planning decision aid to create culturally sensitive, locally tailored safety plans and promote caregiver engagement in home safety during rural ED visits for adolescent suicidality

Plan and Protect (P&P) is a tablet-based, family-centered quality improvement program targeted to rural Northern New England that combines a youth-facing safety-planning module with a caregiver-facing home safety decision aid and youth safety information. The goal is to help adolescents and their caregivers develop concrete, culturally-sensitive safety plans during emergency department visits.

Inny: Care as usual

Outcomes for adolescents and their caregivers enrolled during the pre-implementation (usual care) periods at each hospital will be compared to outcomes for those enrolled after their hospital implements the P&P program as quality improvement

Adolescents and caregivers will receive treatment as usual at the Emergency Department.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Improved Home Safety (caregiver)
Ramy czasowe: 30 and 90 days after ED visit

Reduced access to firearms and medications at home. This will be collected with five questions about presence of medications and firearms at home, if they are stored unlocked, and if firearms are loaded. We will measure improvement in safety across the time frame.

30 and 90 days after ED visit
Suicide Risk (youth)
Ramy czasowe: 30 and 90 days after ED visit

The Concise Health Risk Tracking (CHRT) is a 9-item survey that assesses suicidal thoughts and behaviors in the past week, with response options ranging 0-4. Total scores range 0-36, with higher scores indicating more severe suicidality. Primary outcome will be assessed relative to the baseline assessment assessed at the time of study enrollment.

30 and 90 days after ED visit

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Suicide Events (youth)
Ramy czasowe: 30 and 90 days after ED visit

A composite measure that includes suicide deaths (ascertained by family report and electronic health record (EHR) review), return ED visits and/or rehospitalization for suicidality (ascertained using survey and EHR review), and suicide attempts (evaluated using four questions from the Youth Risk Behavior Survey augmented by structured EHR review).

30 and 90 days after ED visit
Attendance at Follow-up Mental Healthcare (youth and caregiver)
Ramy czasowe: 30 and 90 days after ED visit

Any mental or emotional health care received after their emergency department visit using a checklist adapted from nationally administered healthcare utilization surveys, augmented by EHR review. Survey response categories (primary care, mental health provider, outpatient/urgent care, emergency department, school based care) were derived from health service use domains captured in the Medical Expenditure Panel Survey.

30 and 90 days after ED visit
Reduced Access to Firearms at Home (caregiver)
Ramy czasowe: 30 and 90 days after ED visit

Improved home safety with respect to firearm access. This will be collected with three questions about presence of firearms at home, if they are stored unlocked, and if they are loaded. We will measure improvement in safety across the time frame.

30 and 90 days after ED visit
Reduced Access to Medications at Home (caregiver)
Ramy czasowe: 30 and 90 days after ED visit

Improved home safety with safer storage of medications. This will be collected with two questions about presence of medications at home and if they are stored unlocked. We will measure improvement in safety across the time frame.

30 and 90 days after ED visit
Pessimism (youth)
Ramy czasowe: 30 and 90 days post-ED visit

A 2-item subscale of the Concise Health Risk Tracking (CHRT) that measures negative outlook, with response options ranging 0-4. Total scores range 0-8, with higher scores indicating greater pessimism.

30 and 90 days post-ED visit
Helplessness (youth)
Ramy czasowe: 30 and 90 days after ED visit

A 2-item subscale of the Concise Health Risk Tracking (CHRT) that measures perceived lack of self-control, with response options ranging 0-4. Total scores range 0-8, with higher scores indicating greater feelings of helplessness.

30 and 90 days after ED visit
Despair (youth)
Ramy czasowe: 30 and 90 days after ED visit

A 2-item subscale of the Concise Health Risk Tracking (CHRT) that measures despair, with response options ranging 0-4. Total scores range 0-8, with higher scores indicating more severe discouragement.

30 and 90 days after ED visit
Suicidal thoughts (youth)
Ramy czasowe: 30 and 90 days after ED visit

A 3-item subscale of the Concise Health Risk Tracking (CHRT) that measures suicidal thoughts and planning, with response options ranging 0-4. Total scores range 0-12, with higher scores indicating increased suicidal thoughts and planning.

30 and 90 days after ED visit

Inne miary wyników

Miara wyniku
Opis środka
Ramy czasowe
Change in Efficacy to Cope with Suicidal Thoughts and Urges Scale (primary target mechanism)
Ramy czasowe: 30 and 90 days after ED visit

The Efficacy to Cope with Suicidal Thoughts and Urges Scale was designed to measure children's abilities to manage suicide-related thoughts and impulses. It contains 10 coping skills and children rate their confidence in their ability to use each coping skill to manage their suicidality. Responses range from 0 to 10 with 0 = Not at all confident, 5 = Somewhat confident, and 10 = Extremely confident.

30 and 90 days after ED visit
Change in Parental Perceptions of Teen Suicide Risk (secondary target mechanism)
Ramy czasowe: 30 and 90 days after ED visit

This 3-item measure looks at parental understanding of their teen's suicide risk. Answer choices range from 0 (not at all confident) to 10 (completely confident), with an anchor of 5 (somewhat confident).

30 and 90 days after ED visit
Change in Patient Perceptions of Their Own Suicide Risk (secondary target mechanism)
Ramy czasowe: 30 and 90 days after ED visit

This 3-item self-report measure examines how at risk a patient believes they are. It is scored on a 5-point Likert from 0-4 where higher = greater perceived risk and has a total possible score of 15.

30 and 90 days after ED visit
Change in Parental Self-Efficacy to Support Teens During a Suicidal Crisis (secondary target mechanism)
Ramy czasowe: 30 and 90 days after ED visit

This 9-item scale measures parent confidence regarding their ability to engage in activities to prevent or assist their child in managing a suicidal crisis. Answer choices range from 0 (not at all confident) to 10 (completely confident), with an anchor of 5 (somewhat confident).

30 and 90 days after ED visit

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Śledczy

  • Główny śledczy: JoAnna K Leyenaar, MD, PhD, MPH, Dartmouth College

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

3 sierpnia 2026

Zakończenie podstawowe (Szacowany)

30 kwietnia 2029

Ukończenie studiów (Szacowany)

30 kwietnia 2029

Daty rejestracji na studia

Pierwszy przesłany

19 grudnia 2025

Pierwszy przesłany, który spełnia kryteria kontroli jakości

6 stycznia 2026

Pierwszy wysłany (Rzeczywisty)

8 stycznia 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

2 października 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

29 września 2026

Ostatnia weryfikacja

1 września 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • STUDY02002568
  • 5R01NR021638-02 (Grant/umowa NIH USA)

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

TAK

Opis planu IPD

Data will be uploaded into the NIMH Data Archive (NDA).

Data will be collected from approximately 275 adolescents 12-17 years of age and 275 parents or caregivers. Measures include:

  1. Sociodemographic characteristics of adolescents and caregivers
  2. Follow-up mental health care
  3. DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure for Youth Self-report
  4. Efficacy to Cope with Suicidal Thoughts and Urges Scale for Youth Self-report
  5. Self-Assessed Expectations of Suicide Risk for Youth
  6. Parental Self-Efficacy to Support Teens During a Suicidal Crisis
  7. Concise Health Risk Tracking - Self-Report (CHRT-SR)
  8. Caregiver and adolescent-reported firearms in home/on property (yes/no) and firearm storage practices
  9. Caregiver- and adolescent-reported medications in home (yes/no) and medication storage practices

Ramy czasowe udostępniania IPD

All data will be deposited to NDA starting 12 months after the award begins and will be deposited every six months thereafter following the usual NDA data submission dates.

Kryteria dostępu do udostępniania IPD

Per NDA access requirements and protocols.

Typ informacji pomocniczych dotyczących udostępniania IPD

  • PROTOKÓŁ BADANIA

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj